Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01907074 · ClinicalTrials.gov registry record · Phase 2
Quantitative Liver Function Tests Using Cholates
A Phase 2 study, sponsored by Baylor Research Institute.
- Terminated
- Registry status
- Phase 2
- Development phase
- 103
- Enrollment target
NCT01907074 is a Phase 2 study that was terminated before completion, run by Baylor Research Institute. The registered enrollment target is 103 participants.
The verdict
NCT01907074, a Phase 2 study, was terminated before completion, sponsored by Baylor Research Institute.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 103 participants
- Enrollment target
Study Summary
As the treatments for liver disease and the availability of liver transplantation have progressed, the number of patients with end stage liver disease continues to increase. This has increased the need to risk-stratify patients with cirrhosis to better direct their treatments and provide an accurate prognosis for their outcomes. The traditional assessment of the liver patient has been limited to imaging, static measures of "liver function tests" and liver biopsy. This protocol is designed to increase the spectrum of tests in the evaluation of the patient with end stage liver disease.
Interventions
- DRUG Cholates
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 103 participants |
| Start Date | 2011-06-23 |
| Est. Completion | 2025-05-20 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01907074
The ClinicalTrials.gov registry entry for NCT01907074 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 103 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor Research Institute, which has 180 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cholates is the first listed.
NCT01907074 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01907074 about?
NCT01907074 is a clinical study titled "Quantitative Liver Function Tests Using Cholates". As the treatments for liver disease and the availability of liver transplantation have progressed, the number of patients with end stage liver disease continues to increase. This has increased the need to risk-stratify patients with cirrhosis to better direct their treatments and provide an accurate...
What is the current status of trial NCT01907074?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 103 participants. The study started on 2011-06-23. Estimated completion is 2025-05-20.
What interventions are being tested in trial NCT01907074?
The interventions under investigation include: Cholates (DRUG).
Who is sponsoring clinical trial NCT01907074?
This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.